drug · oligonucleotide
salanersen
Phase 3updated 3mo agoby $BIIB BIOGEN INC.🔗 ChEMBL
Phase 3community read0 votes
Oligonucleotide drug with a maximum clinical stage of Phase 3, with 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
Trials studying salanersen
- phase3A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
- phase3A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam
- phase3A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 15m ago
Found something off?
comments(0)
5-min edit window · permanent after that